Inhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson’s disease.

Inhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson’s disease.
Related ArticlesInhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain Res. 2021 Jan 07;:147266 Authors: Wang Y, Yao L, Gao S, Zhang G, Zhang Q, Liu W, Zhou Y, Sun Y, Feng J, Liu J Abstract Levodopa-induced dyskinesia (LID) is experienced by most patients of Parkinson's disease (PD) upon the long-term use ... read more
Source: PubMedPublished on 2021-01-11